BIO-TECHNE Corp vs Verizon Communications Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Verizon Communications Inc trades at $43.74 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 16.3× BIO-TECHNE Corp's market cap, and Verizon Communications Inc pays the higher dividend (6.51%). Which is the better fit depends on your goals.
| TECH | VZ | |
|---|---|---|
Market Cap | $11.16B | $181.64B |
Sector | Health | Media |
52-Week High | $72.12 | $51.38 |
52-Week Low | $43.31 | $38.40 |
Enterprise Value | $11.24B | $369.14B |
Dividend Yield | 0.45% | 6.51% |
Volume | — | 22,584,735 |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →